191 results on '"Bae, Sang-Byung"'
Search Results
2. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer
3. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients
4. Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
5. The BRAF mutation is associated with the prognosis in colorectal cancer
6. Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer pain
7. TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy
8. A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
9. Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer
10. Observational study of efficacy, safety, and tolerability of fentanyl in Korean cancer patients (OASIS)
11. Expression of AMP‑activated protein kinase/ten‑eleven translocation 2 and their clinical relevance in colorectal cancer
12. Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
13. Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
14. Successful Eradication of Relapsed Primary Effusion Lymphoma with High-Dose Chemotherapy and Autologous Stem Cell Transplantation in a Patient Seronegative for Human Immunodeficiency Virus
15. Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer
16. Medical Treatment of Cancer Pain: Drug Therapy according to Guidelines Will Improve the Quality of Life of Cancer Patients
17. Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer
18. Protein kinase, membrane‑associated tyrosine/threonine�1 is associated with the progression of colorectal cancer
19. A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
20. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma
21. The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer
22. Epigenetic inactivation of RUNX3 in colorectal cancer
23. CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer
24. Abstract 4455: Identification of novel oncogene, copine-7 (CPNE7), in colorectal cancer
25. Division of elderly patients in colorectal cancer: Korean national health insurance big data analysis.
26. Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma
27. A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
28. Expressions and Clinical Significances of Angiopoietin-1, Angiopoietin-2, and Tie-2 Receptor in Patients With Colorectal Cancer
29. Clinicopathologic and Prognostic Significance of Transducin-Like Enhancer of Split 1 Protein Expression in Invasive Breast Cancer
30. Abstract 709: In vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients
31. Abstract 708: Defensin-alpha 6 (DEFA6) as a protumorigenic functionin vitroand prognostic marker in colorectal cancer
32. Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer.
33. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis
34. Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer
35. High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer
36. Second-Line Chemotherapy in Advanced Biliary Tract Cancer: A Retrospective Analysis
37. RhoA is associated with invasion and poor prognosis in colorectal cancer
38. Protein kinase, membrane-associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
39. Prevalence of Anemia and Treatment Outcomes after Bariatric Surgery-a Retrospective Korean Study
40. A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study
41. Prospective multicenter study evaluating adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients: a KSWOG (Korean South West Oncology Group) study.
42. Idiopathic erythrocytosis in a patient on chronic hemodialysis
43. Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer
44. Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell
45. Abstract 33: In vitro functional study of Ang 2 in colorectal cancer cell line and the significance of Ang 2 expression in colorectal cancer patients
46. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation
47. Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.
48. A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer.
49. Erratum: Comparative Analysis of Tuberculous Lymphadenitis and Kikuchi Disease of the Neck
50. Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.